أعرض في EDS

Correlation of survival of NSCLC patients given nivolumab with treatment related-eosinophilia, autoimmunity and previous bevacizumab containing regimens

التفاصيل البيبلوغرافية
العنوان: Correlation of survival of NSCLC patients given nivolumab with treatment related-eosinophilia, autoimmunity and previous bevacizumab containing regimens
المؤلفون: Gabriella Misso, Vito Barbieri, Luigi Pirtoli, Gaetana Porto, Graziella D'Arrigo, Cirino Botta, Rocco Giannicola, Pierfrancesco Tassone, Marika Monoriti, Valerio Nardone, Pierpaolo Correale, Pierosandro Tagliaferri, Silvia Zappavigna, Giovanni Tripepi, Michele Caraglia, Antonia Consuelo Falzea, Pierpaolo Pastina
المصدر: Journal of Clinical Oncology. 36:e21008-e21008
بيانات النشر: American Society of Clinical Oncology (ASCO), 2018.
سنة النشر: 2018
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, business.industry, medicine.disease_cause, Blockade, Autoimmunity, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Medicine, Eosinophilia, medicine.symptom, Nivolumab, business, Adverse effect, medicine.drug
الوصف: e21008Background: Programmed-cell-death-receptor-1 (PD-1) blockade by Nivolumab is a promising immunological treatment for metastatic NSCLC patients. It may be associated to adverse events and high...
تدمد: 1527-7755
0732-183X
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::93baa9daf7b3b70d02a8ea283a3c2276Test
https://doi.org/10.1200/jco.2018.36.15_suppl.e21008Test
رقم الانضمام: edsair.doi...........93baa9daf7b3b70d02a8ea283a3c2276
قاعدة البيانات: OpenAIRE
الوصف
تدمد:15277755
0732183X